Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Scarfò

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Hematological Oncology|January 21, 2023
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experienceLuca Laurenti, Lydia Scarfò, Anna Maria Frustaci, et al.
Blood|January 18, 2013
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaElisa ten Hacken, Cristina Scielzo, Maria T S Bertilaccio, et al.
Leukemia & Lymphoma|March 11, 2017
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemiaMaria Giovanna Vilia, Eleonora Fonte, Tania Veliz Rodriguez, et al.
Frontiers in Immunology|May 20, 2021
3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia CellsFrancesca Vittoria Sbrana, Riccardo Pinos, Federica Barbaglio, et al.
Cell Death & Disease|March 18, 2024
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell deathMaria Elena Mantione, Miriam Meloni, Ilenia Sana, et al.
Blood|August 31, 2011
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLLClaudia Fazi, Lydia Scarfò, Lorenza Pecciarini, et al.
Blood|December 19, 2009
A novel Rag2-/-gammac-/--xenograft model of human CLLMaria Teresa Sabrina Bertilaccio, Cristina Scielzo, Giorgia Simonetti, et al.
Blood|March 6, 2013
Targeting B-cell anergy in chronic lymphocytic leukemiaBenedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.
British Journal of Haematology|October 15, 2014
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab eraAndrés J M Ferreri, Marta Bruno-Ventre, Giovanni Donadoni, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Hematological Oncology|January 21, 2023
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experienceLuca Laurenti, Lydia Scarfò, Anna Maria Frustaci, et al.
Blood|January 18, 2013
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaElisa ten Hacken, Cristina Scielzo, Maria T S Bertilaccio, et al.
Leukemia & Lymphoma|March 11, 2017
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemiaMaria Giovanna Vilia, Eleonora Fonte, Tania Veliz Rodriguez, et al.
Frontiers in Immunology|May 20, 2021
3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia CellsFrancesca Vittoria Sbrana, Riccardo Pinos, Federica Barbaglio, et al.
Cell Death & Disease|March 18, 2024
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell deathMaria Elena Mantione, Miriam Meloni, Ilenia Sana, et al.
Blood|August 31, 2011
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLLClaudia Fazi, Lydia Scarfò, Lorenza Pecciarini, et al.
Blood|December 19, 2009
A novel Rag2-/-gammac-/--xenograft model of human CLLMaria Teresa Sabrina Bertilaccio, Cristina Scielzo, Giorgia Simonetti, et al.
Blood|March 6, 2013
Targeting B-cell anergy in chronic lymphocytic leukemiaBenedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.
British Journal of Haematology|October 15, 2014
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab eraAndrés J M Ferreri, Marta Bruno-Ventre, Giovanni Donadoni, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
Pageof 15